Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons
- 5 August 2005
- journal article
- research article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 113 (5) , 557-571
Abstract
Acute elevation of the endogenous NMDA-receptor antagonist kynurenic acid (KYNA) is associated with an increased neuronal activity of rat ventral tegmental area (VTA) dopamine (DA) neurons and disruption in prepulse inhibition (PPI). In the present study, the effects of subchronic exposure to kynurenine and probenecid (20 mg/kg/day and 10 mg/kg/day, respectively for 14 days), aiming at increasing brain KYNA turnover, on rat VTA dopaminergic firing and on PPI were investigated. This treatment increased neuronal firing of VTA DA neurons, changed the response of these neurons to systemically administered nicotine (3–400 g/kg, i.v.) and tended to disrupt PPI. Present results show that the effect on firing of VTA DA neurons by acutely elevated levels of brain KYNA also persists following subchronic exposure. In addition, no adaptive changes seem to occur with regard to the electrophysiological effects of KYNA on VTA DA neurons following subchronic treatment with kynurenine and probenecid.Keywords
This publication has 96 references indexed in Scilit:
- Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophreniaSchizophrenia Research, 2005
- Prostaglandin-mediated control of rat brain kynurenic acid synthesis – opposite actions by COX-1 and COX-2 isoformsJournal of Neural Transmission, 2004
- Glutamate Receptor Subunits are Altered in Forebrain and Cerebellum in Rats Chronically Exposed to the NMDA Receptor Antagonist PhencyclidineNeuropsychopharmacology, 2004
- Inhibitory Action of Clozapine on Rat Ventral Tegmental Area Dopamine Neurons Following Increased Levels of Endogenous Kynurenic AcidNeuropsychopharmacology, 2003
- Safety and Tolerability of the Glutamate Antagonist CGS 19755 (Selfotel) in Patients With Acute Ischemic StrokeStroke, 1995
- Phencyclidine and the midbrain dopamine system: Electrophysiology and behaviorNeurotoxicology and Teratology, 1994
- Neuroprotective Effects of L-Kynurenine on Hypoxia—Ischemia and NMDA Lesions in Neonatal RatsJournal of Cerebral Blood Flow & Metabolism, 1992
- Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activityGeneral Pharmacology: The Vascular System, 1992
- Presence of Kynurenic Acid in the Mammalian BrainJournal of Neurochemistry, 1988
- Quinolinic acid: A potent endogenous excitant at amino acid receptors in CNSEuropean Journal of Pharmacology, 1981